Site Map
-
Corporate
-
For the public
- Menopause and later life
-
Browse all patient information leaflets
- Abdominal hysterectomy
- Information about abortion care
- Abortion care for women from Northern Ireland
- About RCOG guidelines and parallel information for the public
- Acute pelvic inflammatory disease (PID): tests and treatment patient information leaflet
- Air travel and pregnancy patient information leaflet
- Alcohol and pregnancy
- Amniocentesis and chorionic villus sampling patient information leaflet
- Antenatal care for uncomplicated pregnancies
- Assisted vaginal birth (ventouse or forceps)
- Being overweight in pregnancy and after birth
- Beta thalassaemia and pregnancy patient information leaflet
- Birth after previous caesarean patient information leaflet
- Bleeding and/or pain in early pregnancy patient information leaflet
- Blood transfusion, pregnancy and birth patient information leaflet
- Breech baby at the end of pregnancy patient information leaflet
- Cervical smears and pregnancy patient information leaflet
- Cervical stitch patient information leaflet
- Chickenpox and pregnancy patient information leaflet
- Choosing to have a caesarean section
- Cord blood banking patient information leaflet
- Corticosteroids in pregnancy to reduce complications from being born prematurely patient information leaflet
- Patient information for consultation
- Developing patient information leaflets
- Early miscarriage patient information leaflet
- Ectopic pregnancy patient information leaflet
- Endometrial ablation
- Endometriosis patient information leaflet
- Epilepsy in pregnancy
- Female genital mutilation (FGM)
- Genital herpes in pregnancy patient information leaflet
- Gestational diabetes
- Molar pregnancy and gestational trophoblastic disease
- Group B streptococcus (GBS) infection in newborn babies patient information leaflet.
- Group B Streptococcus (GBS) in pregnancy and newborn babies
- Having a small baby
- Healthy eating and vitamin supplements in pregnancy patient information leaflet
- Heavy bleeding after birth (postpartum haemorrhage) patient information leaflet
- HIV and pregnancy patient information leaflet
- Induction of labour: information for the public
- Laparoscopic hysterectomy recovering well leaflet
- Laparoscopy recovering well leaflet
- Long-term pelvic pain patient information leaflet
- Malaria and pregnancy patient information leaflet
- Managing premenstrual syndrome (PMS) patient information leaflet
- Menopause: diagnosis and management
- Mid-urethral sling operation for stress urinary incontinence recovering well leaflet
- Morcellation for myomectomy or hysterectomy - Information for you
- Multiple pregnancy: having more than one baby
- Obstetric Cholestasis patient information page
- Outpatient hysteroscopy
- Ovarian cancer
- Ovarian cysts before the menopause patient information leaflet
- Ovarian hyperstimulation syndrome patient information leaflet
- Pelvic floor repair operation recovering well leaflet
- Pelvic girdle pain and pregnancy
- Pelvic organ prolapse patient information leaflet
- Perineal tears during childbirth – patient information poster
- Physical activity and pregnancy
- Placenta praevia, placenta accreta and vasa praevia
- Polycystic ovary syndrome (PCOS): what it means for your long-term health patient information leaflet
- Pre-eclampsia patient information page
- Pregnancy and breast cancer patient information leaflet
- Pregnancy sickness (nausea and vomiting of pregnancy and hyperemesis gravidarum)
- Premature labour patient information leaflet
- Recovering from surgical management of a miscarriage
- Recreational exercise and pregnancy patient information leaflet
- Recurrent and late miscarriage patient information leaflet
- Reducing the risk of venous thrombosis in pregnancy and after birth patient information leaflet
- Revalidation: How do I know my doctor is up to date? patient information leaflet
- Shoulder dystocia patient information leaflet
- Sickle cell disease and pregnancy patient information leaflet
- Skin conditions of the vulva patient information leaflet
- Smoking and pregnancy patient information leaflet
- Sterilisation for women and men patient information leaflet
- Surgery for stress incontinence
- Care of a third- or fourth-degree tear that occurred during childbirth (also known as obstetric anal sphincter injury OASI)
- Treatment of venous thrombosis in pregnancy and after birth patient information leaflet
- Treatment for symptoms of the menopause
- Turning a breech baby in the womb patient information leaflet
- Umbilical cord prolapse in late pregnancy patient information leaflet
- Understanding how risk is discussed in health care
- Vaginal hysterectomy recovering well leaflet
- When your baby dies before birth patient information leaflet
- When your waters break prematurely
- Why your weight matters during pregnancy and after birth patient information leaflet
- Your baby's movements in pregnancy
- Large loop excision of the transformation zone (LLETZ)
- Postmenopausal bleeding – Poster
- A-Z of medical terms
- About your doctor
- RCOG engagement: Listening to patients
- FAQs from women and the public
- Perineal tears and episiotomies in childbirth
-
Careers and training
-
Starting your O&G career
- Resources for O&G careers
-
Specialty training
-
Assessment and progression through training
- Training matrix
- CiP sign off
- Sign-off by other methodologies (OM)
- ARCP (Annual Review of Competence Progression)
- Induction and appraisal for trainees
- Workplace-based assessments WPBAs
- Multi-source feedback TO1 and TO2 forms
- Recording development and experiences throughout training
- Non-Technical Skills for Surgeons (NOTSS)
- Training Evaluation Form (TEF)
- Certification of training & specialist registration
- Introduction to specialty training in O&G
-
Assessment and progression through training
-
Workforce
- Workforce planning RCOG census
-
Improving workplace behaviours
- RCOG and RCM joint statement on undermining and bullying in the workplace
-
Workplace Behaviour Toolkit
- Module 1: I feel that I have been bullied or undermined
- Module 2: I feel I have witnessed bullying or undermining
- Module 3: I have been accused of bullying or undermining
-
Module 4: I am responsible for a department that has a problem with bullying or undermining
- 4.1 What might poor workplace behaviour in my department look like?
- 4.2 How would I know if there is a problem with poor workplace behaviour in my department?
- 4.3 Why should I address poor workplace behaviour in my department?
- 4.4 What can I do to address a problem with poor workplace behaviour in my department?
- 4.5 How will I know if behaviours in my department improve and what can I do if they do not?
- Module 5: My deanery has a problem with bullying or undermining (for HoS/TPDs)
- Module 6: I am/want to be a Workplace Behaviour Champion
-
Module 7: I want to learn more about workplace behaviour
- 7.1 What is workplace culture and what are poor workplace behaviours?
- 7.2 How do you recognise bullying and undermining?
- 7.3 Does bullying and undermining occur in O&G/maternity care?
- 7.4 What are the effects of poor workplace behaviour and culture on patient safety, the team and quality of training?
- 7.5 What is the law regarding undermining and bullying?
-
Module 8: Addressing poor workplace behaviours and 'calling it out'
- 8.1 What are the important principles to consider when addressing negative behaviours?
- 8.2 What are the principles of 'calling it out with compassion'? (Second messenger system)
- 8.3 What do the second messenger conversations look like in practice?
- 8.4 How do I speak to a person who I feel has behaved poorly towards me?
- 8.5 How do I speak to a person who I feel I have witnessed behaving poorly?
- Acknowledgements
- Supporting our Doctors
- Return to Work Toolkit
- High Court ruling on GMC v Bawa-Garba
- Consultant job planning
- Job plan approval process for new consultants
- Later Career and Retirement Report
- The impact of the redeployment of maternity staff during COVID-19
- Support and resources for AAC Assessors
- Safe staffing
- Roles and responsibilities of a consultant
- O&G Workforce Report 2022
- Academic O&G
-
Working in Britain for non-UK doctors
- Information for EEA doctors
- Medical Training Initiative (MTI) scheme
- Guidance for non-EEA international doctors
- Guidance for refugee doctors
- COVID-19 Updates
-
Training
- Trainee ePortfolio
- RCOG eLearning
-
Courses and events
- RCOG World Congress
-
RCOG webinars
- Genomics in perinatal medicine
- Global rise in caesarean births
- Tackling the abortion education deficit: how to advocate for comprehensive abortion education for healthcare students and providers
- Menopause: What do women want?
- 4D’s for Delay in second stage - (Dilemmas, Decisions, Developments and new Devices for assisted vaginal birth)
- COVID-19 vaccines in pregnancy: a global perspective
- Post-pandemic restoration of gynaecology services and training
- International Women’s Day: webinar
- Information for delegates
- Courses and conferences FAQs
- Information for exhibitors
- Terms and conditions
- Information for Course Convenors
- Virtual Revision Course information for delegates
-
Curriculum
-
Core Curriculum
-
Current Core Curriculum
- Core Curriculum: CiP 1
- Core Curriculum: CiP 2
- Core Curriculum: CiP 3
- Core Curriculum: CiP 4
- Core Curriculum: CiP 5
- Core Curriculum: CiP 6
- Core Curriculum: CiP 7
- Core Curriculum: CiP 8
- Core Curriculum: CiP 9
- Core Curriculum: CiP 10
- Core Curriculum: CiP 11
- Core Curriculum: CiP 12
- Core Curriculum: CiP 13
- Core Curriculum: CiP 14
-
Knowledge Requirements for Core Curriculum 2019
- Knowledge Area 1 Clinical skills
- Knowledge Area 2 Teaching and research
- Knowledge Area 3 Core surgical skills
- Knowledge Area 4 Postoperative care
- Knowledge Area 5 Antenatal care
- Knowledge Area 6 Maternal medicine
- Knowledge Area 7 Management of labour
- Knowledge Area 8 Management of delivery
- Knowledge Area 9 Postpartum problems
- Knowledge Area 10 Gynaecological problems
- Knowledge Area 11 Subfertility
- Knowledge Area 12 Sexual and reproductive health
- Knowledge Area 13 Early pregnancy care
- Knowledge Area 14 Gynaecological oncology
- Knowledge Area 15 – Urogynaecology and pelvic floor problems
-
Current Core Curriculum
- ATSMs
- ASMs Advanced Skills Module
- Advanced Professional Module (APM)
-
Subspecialty training curriculum
- Gynaecological Oncology subspecialty training
- Maternal and Fetal Medicine subspecialty training
- Reproductive Medicine subspecialty training
- Urogynaecology subspecialty training
- Ultrasound module: Intermediate ultrasound of early pregnancy complications
- How to apply for subspecialty training
- How subspecialty training is assessed
- Research Approval in Subspecialty Training
- Undertaking subspecialty training as OOPT in another deanery
- Subspecialty training FAQs
- Academic training
- Undergraduate training in O&G
- Foundation training in O&G
- Abortion education hub
- Mesh Complications Management Training Pathway
-
Core Curriculum
-
Resources and support for trainees
- Training requirements for the matrix FAQs
- Advice and support for trainees
- SAS and LE Doctors
- Education and training in the context of COVID-19
- eLearning for trainees
- Training ePortfolio
- Out of programme (OOP)
- Less than full-time (LTFT) training
- Resources and support for trainers
- Trainee registration
- Exams
-
CPD & revalidation
-
The CPD framework
- CPD framework FAQs
- CPD Guidance for Appraisers in Obstetrics and Gynaecology
- Tailoring the CPD programme to you
- The purpose of the new CPD programme
- The 4-step learning process
- Close down of old CPD ePortfolio
- Introduction to CPD
- Advice for CPD providers
- TOG CPD questions
- Which ePortfolio should I use?
- CPD special circumstances guidance
- Reflection
- CPD for international doctors
- eLearning for CPD
- Video guidance for CPD
- CPD ePortfolio
- Revalidation
- Appraisal
- CPD registration
- Guidance on using CPD ePortfolio
-
The CPD framework
-
Awards
- National Clinical Impact Awards 2022
- Annual Academic Award
- David Liu Prize
- Eardley Holland Medal
- Eden Travelling Fellowship in Obstetrics and Gynaecology
- EGA Hospital Charity Travelling Fellowship in Memory of Anne Boutwood
- Edgar Gentilli Prize
- Endometriosis Millennium Fund
- Florence and William Blair Bell Research Fellowship
- Harold Malkin Prize
- Herbert Erik Reiss Memorial Case History Prize
- John Lawson Prize
- Kolkata Eden Hospital Annual Prize
- Scientific Undergraduate Academic Prize
- Submitting your application
- Target Ovarian Cancer Essay Prize
- Tim Chard Case History Prize
- William Blair Bell Memorial Lecture
- Women's Visiting Gynaecological Club Prize
-
Starting your O&G career
-
Guidance
-
Browse all guidance
-
Green-top Guidelines
- Amniocentesis and Chorionic Villus Sampling (Green-top Guideline No. 8)
- Antenatal corticosteroids to reduce neonatal morbidity and mortality (Green-top Guideline No. 74)
- Antenatal Corticosteroids to Reduce Neonatal Morbidity (Green-top Guideline No. 7)
- Assisted Vaginal Birth (Green-top Guideline No. 26)
- Diagnosis and Management of Ectopic Pregnancy (Green-top Guideline No. 21)
- Antepartum Haemorrhage (Green-top Guideline No. 63)
- Birth after Previous Caesarean Birth (Green-top Guideline No. 45)
- Blood Transfusions in Obstetrics (Green-top Guideline No. 47)
- Pregnancy and Breast Cancer (Green-top Guideline No. 12)
- Care after non-invasive pre-natal testing (Green-top Guideline No. 76)
- Care of Women Presenting with Suspected Preterm Prelabour Rupture of Membranes from 24+0 Weeks of Gestation (Green-top Guideline No. 73)
- Care of Women with Obesity in Pregnancy (Green-top Guideline No. 72)
- Cervical cerclage (Green-top Guideline No. 75)
- Cervical Cerclage (Green-top Guideline No. 60)
- Chickenpox in Pregnancy (Green-top Guideline No. 13)
- The Initial Management of Chronic Pelvic Pain (Green-top Guideline No. 41)
- Early Pregnancy Loss, Management (Green-top Guideline No. 25)
- Endometriosis, Investigation and Management (Green-top Guideline No. 24)
- Epilepsy in Pregnancy (Green-top Guideline No. 68)
- External Cephalic Version and Reducing the Incidence of Term Breech Presentation (Green-top Guideline No. 20a)
- Female Genital Mutilation and its Management (Green-top Guideline No. 53)
- Genital Herpes in Pregnancy, Management (Green-top Guideline No. 30)
- Gestational Trophoblastic Disease (Green-top Guideline No. 38)
- Prevention of Early-onset Group B Streptococcal Disease (Green-top Guideline No. 36)
- HIV in Pregnancy, Management (Green-top Guideline No. 39)
- Hysteroscopy, Best Practice in Outpatient (Green-top Guideline No. 59)
- Management of Inherited Bleeding Disorders in Pregnancy (Green-top Guideline No. 71)
- Laparoscopic Injuries (Green-top Guideline No. 49)
- Late Intrauterine Fetal Death and Stillbirth (Green-top Guideline No. 55)
- The Diagnosis and Treatment of Malaria in Pregnancy (Green-top Guideline No. 54b)
- Malaria in Pregnancy, Prevention (Green-top Guideline No. 54A)
- Management of Bladder Pain Syndrome (Green-top Guideline No. 70)
- Management of Breech Presentation (Green-top Guideline No. 20b)
- Management of Endometrial Hyperplasia (Green-top Guideline No. 67)
- Maternal Collapse in Pregnancy and the Puerperium (Green-top Guideline No. 56)
- Management of Monochorionic Twin Pregnancy (Green-top Guideline No. 51)
- Obstetric Cholestasis (Green-top Guideline No. 43)
- Ovarian Cysts in Postmenopausal Women (Green-top Guideline No. 34)
- The Management of Ovarian Hyperstimulation Syndrome (Green-top Guideline No. 5)
- Ovarian Masses in Premenopausal Women, Management of Suspected (Green-top Guideline No. 62)
- Management of Suspected Ovarian Masses in Premenopausal Women (Green-top Guideline No. 62)
- Pelvic Inflammatory Disease (Green-top Guideline No. 32)
- Placenta Praevia and Placenta Accreta: Diagnosis and Management (Green-top Guideline No. 27a)
- Long-term Consequences of Polycystic Ovary Syndrome (Green-top Guideline No. 33)
- Post-Hysterectomy Vaginal Vault Prolapse (Green-top Guideline No. 46)
- Prevention and Management of Postpartum Haemorrhage (Green-top Guideline No. 52)
- Premenstrual Syndrome, Management (Green-top Guideline No. 48)
- Preterm Labour, Tocolytic Drugs (Green-top Guideline No. 1B)
- Preterm Prelabour Rupture of Membranes (Green-top Guideline No. 44)
- The Investigation and Treatment of Couples with Recurrent Miscarriage (Green-top Guideline No. 17)
- Reduced Fetal Movements (Green-top Guideline No. 57)
- The Use of Anti-D Immunoglobulin for Rhesus D Prophylaxis (Green-top Guideline No. 22)
- Bacterial Sepsis following Pregnancy (Green-top Guideline No. 64b)
- Sepsis in Pregnancy, Bacterial (Green-top Guideline No. 64a)
- Severe Pre-eclampsia/Eclampsia, Management (Green-top Guideline No. 10a)
- Shoulder Dystocia (Green-top Guideline No. 42)
- Sickle Cell Disease in Pregnancy, Management of (Green-top Guideline No. 61)
- Small-for-Gestational-Age Fetus, Investigation and Management (Green-top Guideline No. 31)
- Management of Beta Thalassaemia in Pregnancy (Green-top Guideline No. 66)
- The Management of Nausea and Vomiting of Pregnancy and Hyperemesis Gravidarum (Green-top Guideline No. 69)
- The Management of Women with Red Cell Antibodies during Pregnancy (Green-top Guideline No. 65)
- Third- and Fourth-degree Perineal Tears, Management (Green-top Guideline No. 29)
- Reducing the Risk of Thrombosis and Embolism during Pregnancy and the Puerperium (Green-top Guideline No. 37a)
- Thrombosis and Embolism during Pregnancy and the Puerperium: Acute Management (Green-top Guideline No. 37b)
- Umbilical Cord Prolapse (Green-top Guideline No. 50)
- Urodynamic Stress Incontinence, Surgical Treatment (Green-top Guideline No. 35)
- Vasa Praevia: Diagnosis and Management (Green-top Guideline 27b)
- Venous Thromboembolism and Hormonal Contraception (Green-top Guideline No. 40)
- Venous Thromboembolism and Hormone Replacement Therapy (Green-top Guideline No. 19)
- Vulval Skin Disorders, Management (Green-top Guideline No. 58)
-
Scientific Impact Papers
- Acupuncture and Chinese Herbal Medicine for Women with Chronic Pelvic Pain (Scientific Impact Paper No. 30)
- Air Travel and Pregnancy (Scientific Impact Paper No. 1)
- Alternatives to HRT for the Management of Symptoms of the Menopause (Scientific Impact Paper No. 6)
- Antenatal and Postnatal Analgesia (Scientific Impact Paper No. 59)
- Antithrombotics in the Prevention of Recurrent Pregnancy Loss, The Use of (Scientific Impact Paper No. 26)
- Bariatric Surgery in the Management of Female Fertility, The Role of (Scientific Impact Paper No. 17)
- Botulinum Toxin for an Overactive Bladder (Scientific Impact Paper No. 42)
- Changing Role of the Gynaecologist in the Management of Women with Cancer (Scientific Impact Paper No. 10)
- Chemical Exposures During Pregnancy: Dealing with Potential, but Unproven, Risks to Child Health (Scientific Impact Paper No. 37)
- Clamping of the Umbilical Cord and Placental Transfusion (Scientific Impact Paper No. 14)
- Congenital Cytomegalovirus Infection: Update on Treatment (Scientific Impact Paper No. 56)
- Developing New Pharmaceutical Treatments for Obstetric Conditions (Scientific Impact Paper No. 50)
- Diagnosis and Treatment of Gestational Diabetes (Scientific Impact Paper No. 23)
- Diagnostic Biomarkers for Predicting Adverse Early Pregnancy Outcomes (Scientific Impact Paper No. 58)
- Elective Egg Freezing for Non-Medical Reasons (Scientific Impact Paper No. 63)
- Endometrial Cancer in Obese Women (Scientific Impact Paper No. 32)
- Enhanced Recovery in Gynaecology (Scientific Impact Paper No. 36)
- Epigenetics and Reproductive Medicine (Scientific Impact Paper No. 57)
- Evaluating misoprostol and mechanical methods for induction of labour (Scientific Impact Paper No. 68)
- Evaluating New Screening Methodologies (Scientific Impact Paper No. 20)
- Evidence Can Influence Clinical Practice, How (Scientific Impact Paper No. 28)
- Evidence to Support the Clinical Utility of Prenatal Exome Sequencing in the Evaluation of the Fetus with Congenital Anomalies (Scientific Impact Paper No. 64)
- Fertility-sparing Treatments in Gynaecological Cancers (Scientific Impact Paper No. 35)
- Fetal Scalp Lactate as an Alternative to Scalp pH, Is it Time for UK Obstetricians to Accept (Scientific Impact Paper No. 47)
- Immunological Testing and Interventions for Reproductive Failure (Scientific Impact Paper No. 5)
- Induction of Labour at Term in Older Mothers (Scientific Impact Paper No. 34)
- Intrauterine Infection and Perinatal Brain Injury (Scientific Impact Paper No. 3)
- Life Course Approach to Women's Health Care, Why Should we Consider a (Scientific Impact Paper No. 27)
- Local Endometrial Trauma (Endometrial Scratch): A Treatment Strategy to Improve Implantation Rates (Scientific Impact Paper No. 54)
- Magnesium Sulphate to Prevent Cerebral Palsy following Preterm Birth (Scientific Impact Paper No. 29)
- Management of Ascites in Ovarian Cancer Patients (Scientific Impact Paper No. 45)
- Management of Female Malignant Ovarian Germ Cell Tumours (Scientific Impact Paper No.52)
- Management of Women with a Genetic Predisposition to Gynaecological Cancers (Scientific Impact Paper No. 48)
- Mesh in Gynaecological Surgery, The Use of (Scientific Impact Paper No. 19)
- Metformin Therapy for the Management of Infertility in Women with Polycystic Ovary Syndrome (Scientific Impact Paper No. 13)
- Multiple Pregnancy Following Assisted Reproduction (Scientific Impact Paper No. 22)
- Non-invasive Prenatal Testing for Chromosomal Abnormality using Maternal Plasma DNA (Scientific Impact Paper No. 15)
- Nutrition in Pregnancy (Scientific Impact Paper No. 18)
- Optimum Surgery in Advanced-stage Ovarian Cancer (Scientific Impact Paper No. 25)
- Patient-reported Outcome Measures in Gynaecology (Scientific Impact Paper No. 31)
- Periconceptional Folic Acid and Food Fortification in the Prevention of Neural Tube Defects (Scientific Impact Paper No. 4)
- Perinatal Management of Pregnant Women at the Threshold of Infant Viability – the Obstetric Perspective (Scientific Impact Paper No. 41)
- Perinatal Risks Associated with IVF (Scientific Impact Paper No. 8)
- Prenatal Management of Pregnancies at Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT) (Scientific Impact Paper No. 61)
- Preterm Labour, Antibiotics and Cerebral Palsy (Scientific Impact Paper No. 33)
- Progress in Cervical Screening in the UK (Scientific Impact Paper No. 7
- Reproductive Ageing (Scientific Impact Paper No. 24)
- Reproductive Implications and Management of Congenital Uterine Anomalies (Scientific Impact Paper No. 62)
- Reproductive Outcomes after Local Treatment for Preinvasive Cervical Disease (Scientific Impact Paper No.21)
- Reproductive Trends and Assisted Reproduction Technologies (Scientific Impact Paper No. 11)
- Risk-Reducing Salpingo-Oophorectomy and the Use of Hormone Replacement Therapy Below the Age of Natural Menopause (Scientific Impact Paper No. 66)
- Sentinel Lymph Node Biopsy in Endometrial Cancer (Scientific Impact Paper No.51)
- Sex Steroid Treatment for Pubertal Induction and Replacement in the Adolescent Girl (Scientific Impact Paper No. 40)
- Stem Cell Therapies in Obstetrics and Gynaecology (Scientific Impact Paper No. 38)
- Targeted Therapies for the Management of Ovarian Cancer (Scientific Impact Paper No. 12)
- The Combined Use of Ultrasound and Fetal Magnetic Resonance Imaging for a Comprehensive Fetal Neurological Assessment in Fetal Congenital Cardiac Defects (Scientific Impact Paper No. 60)
- The Distal Fallopian Tube as the Origin of Non-uterine Pelvic High-grade Serous Carcinomas (Scientific Impact Paper No. 44)
- The Effect of Surgery for Endometriomas on Fertility (Scientific Impact Paper No. 55)
- The Role of Natural Killer Cells in Human Fertility (Scientific Impact Paper No. 53)
- The Use of Adhesion Prevention Agents in Obstetrics and Gynaecology (Scientific Impact Paper No. 39)
- Therapies Targeting the Nervous System for Chronic Pelvic Pain Relief (Scientific Impact Paper No. 46)
- Ultrasound from Conception to 10+0 Weeks of Gestation (Scientific Impact Paper No. 49)
- Umbilical Cord Blood Banking (Scientific Impact Paper No. 2)
- Vaccination Against Cervical Cancer (Scientific Impact Paper No. 9)
- Vitamin D in Pregnancy (Scientific Impact Paper 43)
- Vitamin Supplementation in Pregnancy (Scientific Impact Paper No. 16)
- Understanding the Relationship Between Social Determinants of Health and Maternal Mortality (Scientific Impact Paper No. 67)
- Uterine Transplantation (Scientific Impact Paper No. 65)
-
Consent Advice
- Abdominal Hysterectomy for Benign Conditions (Consent Advice No. 4)
- Amniocentesis (Consent Advice No. 6)
- Caesarean Section (Consent Advice No. 7)
- Caesarean Section for Placenta Praevia (Consent Advice No. 12)
- Diagnostic Hysteroscopy Under General Anaesthesia (Consent Advice No. 1)
- Diagnostic Laparoscopy (Consent Advice No. 2)
- Laparoscopic Management of Tubal Ectopic Pregnancy (Consent Advice No. 8)
- Morcellation for myomectomy or hysterectomy (Consent Advice No. 13)
- Operative Vaginal Delivery (Consent Advice No. 11)
- Repair of Third- and Fourth-degree Perineal Tears Following Childbirth (Consent Advice No. 9)
- Vaginal Surgery for Prolapse (Consent Advice No. 5)
- Female Sterilisation (Consent Advice No. 3)
- Surgical Management of Miscarriage and Removal of Persistent Placental or Fetal Remains (Consent Advice No. 10 Joint with AEPU)
-
Clinical Governance Advice
- Development of RCOG Green-top Guidelines: Policies and Processes (Clinical Governance Advice No. 1a)
- Obtaining Valid Consent (Clinical Governance Advice No. 6)
- Obtaining Valid Consent for Complex Gynaecological Surgery (Clinical Governance Advice No. 6b)
- Obtaining Valid Consent to Participate in Perinatal Research Where Consent is Time Critical (Clinical Governance Advice No. 6a)
- Presenting Information on Risk (Clinical Governance Advice No. 7)
- Understanding Audit (Clinical Governance Advice No. 5)
- Development of RCOG Green-top Guidelines: Consensus Methods for Adaptation of RCOG Green-top Guidelines (Clinical Governance Advice No. 1d)
- Improving Patient Safety: Risk Management for Maternity and Gynaecology (Clinical Governance Advice No. 2)
-
Good Practice Papers
- Advice on Returning to Clinical Practice after a Period of Absence (Good Practice No. 1)
- Cardiac Disease and Pregnancy (Good Practice No. 13)
- Classification of Urgency of Caesarean Section – a Continuum of Risk (Good Practice No. 11)
- Disposal following Pregnancy Loss before 24 Weeks of Gestation (Good Practice No. 5)
- Gynaecology: Emergency Services Standards of Practice and Service Organisation (Good Practice No. 9)
- Improving Patient Handover (Good Practice No. 12)
- Labour Ward Solutions (Good Practice No. 10)
- Management of Women with Mental Health Issues during Pregnancy and the Postnatal Period (Good Practice No.14)
- Maternity Dashboard: Clinical Performance and Governance Score Card (Good Practice No. 7)
- Minimum Standards in Respect of Elective Work Performed during a Consultant’s Absence (Good Practice No. 3)
- Reconfiguration of Women's Services in the UK (Good Practice No. 15)
- Registration of Stillbirths and Certification for Pregnancy Loss Before 24 Weeks of Gestation (Good Practice No. 4)
- Responsibility of Consultant On-call (Good Practice No. 8)
- The Role of Emergency and Elective Interventional Radiology in Postpartum Haemorrhage (Good Practice No. 6)
- Patient Safety Alerts
- Best Practice Papers
-
Other guidelines and reports
- Clinical Guidelines for Early Medical Abortion at Home – England
- Fetal Awareness: Review of Research and Recommendations for Practice
- Management of Genital Herpes in Pregnancy
- High Quality Women's Health Care
- Hospital Episode Statistics as a Source of Information on Safety and Quality in Gynaecology to Support Revalidation
- Obtaining Valid Consent to Participate in Perinatal Research Where Consent is Time Critical
- Potential for harm as a result of off-licence use of Hibitane (chlorhexidine 1%)
- Providing Equity of Critical and Maternity Care for the Critically Ill Pregnant or Recently Pregnant Woman
- Standards for Gynaecology
- Standards for Maternity Care
- Termination of Pregnancy for Fetal Abnormality in England, Scotland and Wales
- The Care of Women Requesting Induced Abortion (Evidence-based Clinical Guideline No. 7)
- Uterine Artery Embolisation in the Management of Fibroids
- Valproate Use In Women and Girls Of Childbearing Years
- Guidelines for the Diagnosis and Management of Vulval Carcinoma
- Zika virus infection and pregnancy
- Management of Unscheduled Bleeding in Women Using Hormonal Contraception
-
Green-top Guidelines
-
Coronavirus (COVID-19), pregnancy and women’s health
- Coronavirus (COVID-19), infection in pregnancy
- Vaccination
- Optimising maternity services in coronavirus (COVID-19) pandemic
- Optimising gynaecological services in coronavirus (COVID-19) pandemic
- Reset, Recovery and Restoration
- Education, training and CPD during the pandemic
- Coronavirus (COVID-19) infection and abortion care
- Library services
- Patient safety
- Guidance consultation documents
- RCOG Green-top guidelines app
- RCOG guidelines disclaimer
- Consent
- Reproducing RCOG guidance and patient information
-
Browse all guidance
- Membership
-
About us
- What we do
- History of the College
- Get involved with our work
-
Campaigning and opinions
-
Position statements
- RCOG submission to the DHSC Consultation on ‘Making vaccination a condition of deployment in the health and wider social care sector’
- Position statement: Equitable access to maternity care for refugee, asylum seeking and undocumented migrant women
- Statement from representative bodies for those working in maternity and neonatal services
- Race Equality Taskforce
- Better for Women
- Left for too long: understanding the scale and impact of gynaecology waiting lists
-
Position statements
- Global network
-
Groups and societies
-
The RCOG Centre for Quality Improvement and Clinical Audit
- Each Baby Counts
- National Maternity and Perinatal Audit (NMPA)
- Tommy's National Centre for Maternity Improvement
- OASI
- OASI 2
- COVID Maternity Equality Project (CMEP)
- Genomics at RCOG
- Faculty of Sexual & Reproductive Healthcare (FSRH)
-
Specialist Societies
- Association of Early Pregnancy Units (AEPU)
- British Association of Perinatal Medicine (BAPM)
- British and Irish Association of Robotic Gynaecological Surgeons (BIARGS)
- British Association for Sexual Health and HIV (BASHH)
- British Fertility Society (BFS)
- British Gynaecological Cancer Society (BGCS)
- British Maternal and Fetal Medicine Society (BMFMS)
- British Menopause Society (BMS)
- British Society for Colposcopy and Cervical Pathology (BSCCP)
- British Society for Gynaecological Endoscopy (BSGE)
- British Society for Gynaecological Imaging (BSGI)
- British Society for Paediatric and Adolescent Gynaecology (BritSPAG)
- British Society for the Study of Vulval Disease (BSSVD)
- British Society of Abortion Care Providers (BSACP)
- British Society of Psychosomatic Obstetrics, Gynaecology and Andrology (BSPOGA)
- British Society of Urogynaecology (BSUG)
- Institute of Psychosexual Medicine (IPM)
-
The RCOG Centre for Quality Improvement and Clinical Audit
-
Governance
-
Committees
- Academic Board
- Advanced Training Committee
- Audit and Risk Committee
- Board of Trustees
- Clinical Directors' Forum
- Clinical Quality Assurance Group (CQAG)
- Clinical Quality Board
- Congress Committee
- Disciplinary, Removal and Reinstatement Committee (DRRC)
- DRCOG Sub-committee
- Education Board
- Education Quality Assurance Committee
- Equality, Diversity and Inclusion Committee
- Equivalence Advisory Group
- Examination and Assessment Committee
- Finance and General Purposes Committee (F&GP)
- Global Health Advisory Committee
- Guidelines Committee
- Investment Advisory Panel
- Journals Business Development Committee
- Membership Board
- MTI Committee
- Northern Ireland Committee
- Part 1 & 2 MRCOG Standard Setting committee
- Part 1 MRCOG Sub-committee
- Part 2 MRCOG EMQ Sub-committee
- Part 2 MRCOG SBA Sub-committee
- Part 3 MRCOG Clinical Assessment Sub-committee
- Patient Information Committee
- Patient Safety Committee
- Professional Development Committee
- RCOG eLearning Editorial Board
- RCOG Women’s Network
- Research Committee
- Scientific Advisory Committee
- Scottish Committee
- Specialty Education Advisory Committee (SEAC)
- Subspecialty Committee
- TOG Editorial Board
- Trainees’ Committee
- Trainees' Global Health Committee
- Welsh Executive Committee
- Curriculum Committee
- Officers
- Chief Executive Officer
- Council
-
Committees
-
Policies
- Code of conduct
- Complaints policy and procedure
- Data protection statement
- Data protection policy
- Diversity policy
- Endorsement policy
- Equal opportunities policy
- Franchising policy for RCOG educational courses
- Information Governance Policy
- Publishing links to third-party websites
- Records Management Policy
- Rights and permissions
- Safeguarding policy
- Social media policy
- Travel policy
- Volunteering policy
- Working with industry
- Advertising, sponsorship and corporate opportunities
- Facilities and venue hire
- Journals
-
News
- Medical bodies representing women’s health say move to end telemedicine abortion service will be devastating for women
- RCOG supports government vaccine campaign
- RCOG responds to cervical screening changes in Wales
- RCOG responds to Women’s Health Strategy Vision
- Leading Maternity Royal Colleges urge NHS to avoid redeploying maternity staff
- RCOG welcomes updated COVID-19 working guidance
- Maternity Royal Colleges welcome prioritisation of pregnant women for COVID-19 vaccination
- RCOG responds to Government's booster vaccine roll out
- Maternity Royal Colleges welcome extension to booster COVID-19 vaccine programme
- New safety data from UKHSA provides more evidence that COVID-19 vaccine is safe in pregnancy
- RCOG responds to latest MBRRACE-UK Maternal report
- Understanding the relationship between social determinants of health and maternal mortality
- RCOG calls for urgent research into miscarriage rates
- RCOG and BMS welcome consultation on vaginal HRT
- RCOG welcomes new research from MMHA
- £3 million funding to support the Avoiding Brain Injury in Childbirth programme
- RCOG responds to Lancet report linking adverse birth outcomes to inequality
- RCOG supports calls for international governments to act on climate change
- Maternity Colleges urge pregnant women to have flu vaccine and COVID-19 vaccine this winter
- RCOG, RCPCH and UKHACC call for urgent environmental action to protect the health of children, pregnant women and their babies
- World Patient Safety Day 2021
- Pregnant women eligible for the COVID-19 booster vaccine urged to take up offer
- RCOG responds to latest HSIB report
- RCOG/FSRH respond to reports of 30,000 women’s periods affected after COVID-19 vaccine
- Structural weaknesses in maternity funding exposed by COVID, say maternity Royal Colleges
- Leading medical bodies express disappointment at Government’s decision not to make telemedicine for abortion care permanent
- RCOG and RCM welcome report and draft guidelines for when the state intervenes at birth
- Pregnancy screening algorithm can reduce racial disparities in baby deaths, research shows
- RCOG concerned that mandatory vaccination will impact safe delivery of maternity services
- Latest UKHSA data provides more evidence on the safety of COVID-19 vaccines in pregnancy
- RCOG welcomes new NMPA audit study
- Top tips for healthcare professionals: Cervical screenings
- RCOG responds to HMP Styal report
- New draft guideline outlines best practice for treating recurrent miscarriage
- Maternity Colleges welcome latest MBRRACE-UK report
- RCOG supports calls from NHS to pregnant women to get vaccinated against COVID-19
- RCOG responds to HMP Bronzefield report
- RCOG responds to CQC maternity services report
- FSRH and RCOG launch Telemedicine Facts campaign
- RCOG to mark World Patient Safety Day
- RCOG welcomes increase on storage limits for eggs, sperm and embryos
- RCOG/ACOG statement on the situation in Afghanistan
- RCOG response to the Mail on Sunday article
- RCOG statement on the situation in Ukraine
- RCOG welcomes plans to improve mental health support for pregnant women and new parents
- New WHO abortion guidelines pivotal to end unsafe abortions globally
- RCOG statement on sexual harassment in the O&G workforce
- The majority of women who gave birth in December 2021 were vaccinated
- RCOG calls for an urgent review of how UK Government cares for pregnant women within the asylum system
- RCOG calls on MPs to vote in favour of telemedicine for early medical abortion being made permanent
- Dark day for maternity services as RCOG responds to the final Ockenden review
- Parliament votes to make telemedicine for early medical abortion permanent in England
- More than half a million women face prolonged waits for gynaecology care
- Our planet, our health
- Monthly blog from RCOG President
- A Royal opening of RCM's and RCOG's new headquarters in London
- RCOG welcomes HRT tsar appointment
- Medical organisations respond jointly to supply shortages of HRT
- RCOG welcomes new NMPA study
- Monthly blog from RCOG President – May 2022
- COVID-19 vaccination associated with 15% reduction in stillbirths in pregnant women
- Educating the next generation of abortion providers – how to get it right.
- Maternity Royal Colleges welcome increased COVID-19 vaccine uptake in pregnant women
- RCOG Women’s Voices Lead appointed cross-bench peer
- RCOG responds to Birthrights inquiry into racial injustice in maternity care
- RCOG responds to Five X More’s The Black Maternity Experiences Survey
- Contact us
- Site search
-
For the public